Allogene Therapeutics, Inc. (ALLO) Institutional Ownership

Institutions by Trading Activity

Ownership Statistics

222,038,680Shares Outstanding

161,907,482Shares held by institutions

$386,149,345Value of institutional holdings

72.92%Institutional ownership %

3.00%Shares Changed QoQ

166No. of institutional investors

Shares Owned by Institutions

Shares Purchased/Sold by Institutions

Ownership Summary

Allogene Therapeutics, Inc. (NASDAQ:ALLO) has 166 institutional investors that have filed 13F reports for the period ending December 2025.

Their combined ownership stood at 71.8% of outstanding shares in December 2025, down from 73.8% in September 2025.
They increased total shares held in Allogene Therapeutics by 2.06% from the prior quarter, while the number of investors in ALLO decreased 3.49% year over year.
Of these 166 holders, 79 added to their stakes in Allogene Therapeutics, 46 trimmed positions, and 41 made no changes.
In total, institutional investors held 159.46Mn shares in Allogene Therapeutics as of December 2025, up by 3.21Mn shares quarter on quarter, and down 30.01Mn shares year over year.
Pfizer Inc leads ownership in ALLO with 22.03Mn shares as of December 31, 2025, equal to 9.92% of outstanding shares.
Leading buyers of Allogene Therapeutics shares for the quarter ending December 2025 were Goldman Sachs Group Inc (3.38Mn), Kalehua Capital Management LLC (2.55Mn), Candriam S.C.A. (2.31Mn), Patient Square Capital LP (1.98Mn), PRIMECAP MANAGEMENT CO/CA/ (1.06Mn).
The largest sales of ALLO for the quarter ending December 2025 came from UBS Group AG (2.18Mn), CITADEL ADVISORS LLC (1.86Mn), MILLENNIUM MANAGEMENT LLC (1.55Mn), DIMENSIONAL FUND ADVISORS LP (1.13Mn), Royal Bank Of Canada (1.05Mn).
Allogene Therapeutics's 10 largest shareholders as of December 2025 include Pfizer Inc (22.03Mn), TPG GP A, LLC (18.72Mn), BlackRock, Inc. (17.68Mn), CITADEL ADVISORS LLC (12.11Mn), VANGUARD GROUP INC (9.25Mn), PRIMECAP MANAGEMENT CO/CA/ (8.14Mn), Patient Square Capital LP (4.96Mn), Goldman Sachs Group Inc (4.58Mn), GEODE CAPITAL MANAGEMENT, LLC (3.93Mn), Frazier Life Sciences Management, L.P. (3.87Mn) per Business Quant data.

166 Institutional Holders

161,907,482 Total Shares Held

Rows:

Download Data

Owner Name	Date	Shares Held	Change (QoQ)	Change (%)	Value (USD)
Pfizer Inc	31 Dec, 2025	22,032,040	0	0.00%	$30,183,895.00
TPG GP A, LLC	31 Dec, 2025	18,716,306	0	0.00%	$25,641,339.00
BlackRock, Inc.	31 Dec, 2025	17,676,029	161,355	0.92%	$24,216,160.00
CITADEL ADVISORS LLC	31 Dec, 2025	12,111,420	-1,860,137	-13.31%	$16,592,646.00
VANGUARD GROUP INC	31 Dec, 2025	9,251,609	230,839	2.56%	$12,674,704.00
PRIMECAP MANAGEMENT CO/CA/	31 Dec, 2025	8,139,840	1,060,532	14.98%	$11,151,581.00
Patient Square Capital LP	31 Dec, 2025	4,963,756	1,982,360	66.49%	$6,800,346.00
Goldman Sachs Group Inc	31 Dec, 2025	4,578,916	3,375,208	280.40%	$6,273,114.00
GEODE CAPITAL MANAGEMENT, LLC	31 Dec, 2025	3,932,910	99,025	2.58%	$5,388,905.00
Frazier Life Sciences Management, L.P.	31 Dec, 2025	3,868,750	0	0.00%	$5,300,188.00
Woodline Partners LP	31 Dec, 2025	3,500,499	-860,109	-19.72%	$4,795,684.00
TWO SIGMA INVESTMENTS, LP	31 Dec, 2025	3,423,441	39,797	1.18%	$4,690,114.00
Wildcat Capital Management, LLC	31 Dec, 2025	2,920,787	0	0.00%	$4,001,478.00
TWO SIGMA ADVISERS, LP	31 Dec, 2025	2,890,200	108,600	3.90%	$3,959,574.00
State Street Corp	31 Dec, 2025	2,761,400	6,022	0.22%	$3,783,118.00
Kalehua Capital Management LLC	31 Dec, 2025	2,546,129	2,546,129	0.00%	$3,488,197.00
Candriam S.C.A.	31 Dec, 2025	2,305,644	2,305,644	0.00%	$3,158,867.00
RENAISSANCE TECHNOLOGIES LLC	31 Dec, 2025	2,187,084	-706,728	-24.42%	$2,996,305.00
JANE STREET GROUP, LLC	31 Dec, 2025	2,160,383	944,610	77.70%	$2,959,725.00
Aberdeen Group plc	31 Dec, 2025	2,086,332	504,067	31.86%	$2,858,275.00

1 - 20 of 166

Research Tools